ROBERT HOWARD GETZENBERG
Business Address: University
of Pittsburgh
Shadyside
Medical Center
Urology Research G-40
5200 Centre Avenue
E-mail: getzenbergrh@upmc.edu
Pittsburgh,
PA 15232
Business Phone:
(412)
623-3903
Business Fax: (412) 623-3904
Current Address:
Professor
and Director of Research of the Brady Urological Insitute
Johns Hopkins School of Medicine
Marburg 113
600 North Wolfe Street
Baltimore, MD 21287
410-502-3137
fax 410-955-0833
e-mail: rgetzen1@jhmi.edu
UNDERGRADUATE:
Degree Received
1983 –
1987 Rutgers
College, Rutgers University B.A.
w/ High Honors Microbiology
New
Brunswick, New Jersey 1987
GRADUATE:
Degree Received Major
Professor
Dates Attended Name
and Location of Institution and Year and Discipline
1987-1992 Johns
Hopkins University School of Ph.D.
– 1992 Donald
S. Coffey, Ph.D.
Medicine,
Baltimore, Maryland Biochemistry,
Cellular
&
Molecular Biology
POST-GRADUATE:
1992-1994 Yale
University School of Medicine Eric
R. Fearon, M.D., Ph.D.
New
Haven, Connecticut Postdoctoral
Fellowship
Department
of Pathology
ACADEMIC:
2003 – Present Department
of Urology Professor
w/tenure and
University
of Pittsburgh School of Medicine Director
of Urological
Pittsburgh,
Pennsylvania Research
2003 – Present Department
of Pathology Professor
w/tenure
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
2003 – Present Department
of Pharmacology Professor
w/tenure
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
2000 – 2003 Department
of Urology Associate
Professor w/tenure and
University
of Pittsburgh School of Medicine Director
of Urological
Pittsburgh,
Pennsylvania Research
1999 – 2003 Department
of Pathology Associate
Professor w/tenure
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
1999 – 2003 Department
of Pharmacology Associate
Professor w/tenure
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
1994 – 1999 Department
of Pathology Assistant
Professor
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
1995 – 1997 Department
of Surgery Assistant
Professor
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
1995 – 1999 Department
of Medicine Assistant
Professor
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
1995 – 1999 Department
of Pharmacology Assistant
Professor
University
of Pittsburgh School of Medicine
Pittsburgh,
Pennsylvania
1997 – Present Prostate
and Urologic Cancer Program Director
of Research
University
of Pittsburgh Cancer Institute and
Co-Director
1994 – Present Prostate
and Urologic Cancer Program
University
of Pittsburgh Cancer Institute Member
1995 – Present Graduate
Faculty
University
of Pittsburgh School of Medicine Member
1996 – Present Cellular
and Molecular Pharmacology Graduate Program
University
of Pittsburgh School of Medicine Member
1997 – 1998 Cellular
and Molecular Pathology Graduate Program Member,
Executive
University
of Pittsburgh School of Medicine Steering
Committee
1998 – Present Cellular
and Molecular Pathology Graduate Program Associate
Director
University
of Pittsburgh School of Medicine
1999 - 2003 UPCI
Planning and Budget Committee Member
University
of Pittsburgh Cancer Institute
American
Society for Cell Biology 1988
– present
Society
for Basic Urologic Research 1992
– present
American
Association for Cancer Research 1993
– present
American
Urological Association – Affiliate Member 1995
– present
American
Association for Clinical Chemistry – Member 2000
– present
American
Foundation for Urologic Disease – Board of Directors 2003
- present
Caspar
Nannes Memorial Scholarship 1983
– 1987
Rutgers
Club of Washington
Henry
Rutgers Honor Scholar 1987
Rutgers
College
Cap and
Skull Honor Society, High Skull 1987
Rutgers
College
High
Honors in Microbiology 1987
Rutgers
College
First
Prize, Research, NCI National Meeting on 1989
Prostate
Cancer, Prouts Neck, Maine
Swebilius
Cancer Research Award 1992
– 1994
Yale
University School of Medicine
American
Association for Cancer Research Travel Award 1993
Special
Conference on Oncogenes and Antioncogenes
Travel
Award – Society for Basic Urologic Research Fall 1993
Symposium
Shannon
Award – National Cancer Institute, National Institutes 1995
– 1997
of Health
National
Kidney Cancer Association Young Investigator 1996
Honors Convocation
– University of Pittsburgh 1997
Society
for Basic Urologic Research/Merck Young Investigator Award 1998
Pittsburgh
Magazine, “40 under 40” Award 1999
Presenter,
American Cancer Society’s 41st Science Writers Seminar 1999
Honors Convocation
– University of Pittsburgh 2000
Chancellors
Research Award – University of Pittsburgh 2000
_________________________________________________________________________________________________
1.
Refereed
articles.
28.
Horton, M.J. and Getzenberg,
R.H. Rat Seminal Vesicle
Secretory Protein SVS-II Binds DNA with a Preference for 5’ Regulatory Regions
of Secretory Protein Genes:
Presence Among Components of the Nuclear Matrix. Journal of Andrology, 20(2): 7, 1999.
and Monitoring of
Bladder Cancer. Techniques in
Urology, 5 (4): 179-184, 1999.
of Cellular
Biochemistry. 32/33: 183-191, 1999.
In vivo Effects
of Vitamin D (calcitriol) Administration on the Normal Neonatal and
Pre-Pubertal Prostate.
Journal of
Urology, 164, 1812-1818, 2000
R. H. Clinical Usefulness of the Novel Marker, BLCA-4, for
the Detection of Bladder Cancer.
Journal of
Urology, 164: 634-639, 2000.
Evaluation of the
Effect of Spinal Cord Injury (SCI) on serum PSA levels, Urology, 56: 82-86, 2000.
48. Brunagel, G., Vietmeier, B.N., Bauer, A.J., Schoen,
R.E., and Getzenberg, R.H. Nuclear Matrix Protein Alterations
Associated with Colon Cancer Metastasis to the Liver. Clinical Cancer Research, 8: 3039-3045, 2002
55. Getzenberg,
R.H. Urine-Based Assays for Bladder Cancer. Laboratory Medicine, 34: (8) 613-617, 2003.
56. Sakamoto,
S., Yokoyama, M., Prakash, K., Tsuruha, J-I., Masamoto, S., Getzenberg, R.H. and Kakehi, Y. Development of Quantitative Detection
Assays for CYR61 as a New Marker for Benign Prostatic Hyperplasia. Journal of Biomolecular Screening, 8: No: 6: 701-711, 2003.
57. Kasai, M.,
Guerrero-Santoro, J., Friedman, R., Leman E.S., Getzenberg, R.H. and DeFranco, D. B. The Group
3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in
Prostate Cancer Cell
Lines. Cancer Research, 63: 4927-4935, 2003.
58. Kakehi, Y., Segawa,
T., Wu, X-X., Kulkarni, P., Dhir, R., and Getzenberg,
R.H. Down-regulation of Macrophage
Inhibitory Cytokine-1/Prostate Derived Factor in Benign Prostatic
Hyperplasia. The Prostate, 59: 351-356, 2004.
59. Dhir, R., Vietmeier, B., Arlotti, J., Acquafondata,
M., Landsittel, D. Getzenberg, R.H. Early
Identification of
Individuals with Prostate Cancer in “Negative Biopsies”. J. of Urology, 171:1419-1423, 2004.
60. Guzey,
M., Arlotti, J., Acquafondata, M., Jukic, D., Dhir, R., and Getzenberg, R.H. Increased Apoptosis of Periprostatic
Adipose Tissue in VDR Null Mice. Journal of Cellular Biochemistry, in press,
2004.
61. Guzey, M., Luo
J. and Getzenberg, R.H. Vitamin D3 Modulated Gene
Expression Patterns in Primary Prostate
Normal and Cancer Cells. Journal
of Cellular Biochemistry, 93:271-285,
2004.
62. Shah, U.S., and
Getzenberg, R.H. Fingerprinting the Diseased Prostate:
Association Between BPH and Prostate
Cancer. Journal of Cellular
Biochemistry, 91:161-169, 2004.
63. Brunagel,
G., Schoen, R.E., and Getzenberg,
R.H. Colon Cancer Specific
Nuclear Matrix Protein
Alterations
in Human Colonic Adenomatous Polyps.
Journal of Celluar Biochemistry, 91:
365-374, 2004.
64. Van
Le, T-S.T., Myers, J., Konety, B.R., Barder, T., and Getzenberg, R.H.
Functional Characterization of
the Bladder Cancer Marker, BLCA-4.
Clinical Cancer Research, 10: 1384-1391,
2004.
65. Shah, U.S.,
Arlotti, J., Dhir, R., Lu, S., Pirozzi, G., Prakash, K., and Getzenberg, R.H. Androgen Regulation of JM-27 is Associated with
the Diseased Prostate. Journal of
Andrology, 25: 618-624, 2004.
66. Van Le, T-S.T.,
Miller, R., Barder, T., Babjuk, M., Potter D.M., and Getzenberg, R.H. A
Highly Specific
Urine-Based Marker of Bladder Cancer.
Clinical Cancer Research, submitted, 2004.
67. Chen,
J., Davies, B., and Getzenberg, R.H. Diagnostic Markers of Renal Cell
Carcinoma. Journal of Urology, submitted,
2004.
68. Myers, J.M.,
Landsittel, D., and Getzenberg, R.H. Utilization of the Novel Marker,
BLCA-1, for Detection
of Bladder Cancer. Journal of
Urology, submitted, 2004.
69.
Perlmutter, M.A., Dhir, R., Acquafondata, M.B., Hrebinko, R.L. and Getzenberg, R.H. Immunohistochemical
Analysis of Ki-67, Cyclin B1, CENP-F and MCM7 in Human Bladder Cancer. Urologic Oncology, submitted, 2004.
70. Sakamoto,
S., Yokoyama, M., Zhang, X., Prakash, K., Nagao, K., Hatanaka, T., Getzenberg, R.H., and Kakehi, Y. Increased Expression of CYR61, an
Extracellular Matrix Signaling Protein, in Human Benign Prostatic Hyperplasia and Its
Regulation by Lysophosphatidic Acid.
Endocrinology, 145:(6)
2929-2940, 2004.
71. Davies,
B., Chen, J., Leiras, C., Modugno, F.M., Landsittel, D., Dhir, R., Nelson, J.,
and Getzenberg, R.H. Dimming the Future of Survivin
as a Bladder Cancer Biomarker: The Emerging Role of the Prostate. JAMA, submitted, 2004.
72. Paul, B., Dhir, R., Landsittel, D., Hitchens, M.R., and Getzenberg, R. H. Detection
of Prostate Cancer with a Blood-Based Assay for EPCA. Nature Medicine, submitted, 2004.
73. Ouyang,
D.L., Chen, J.J., Getzenberg, R.H.,
and Schoen, R.E. Non-Invasive
Testing for Colorectal Cancer: A Review.
American J. of Gastroenterology, submitted, 2004.
74. Minnery,
C., and Getzenberg, R.H. BPH Cell Viability and Modulation of
JM-27 by Doxazosin and Ibuprofen.
Journal of Urology, submitted, 2004.
2.
Books,
Chapters and Reviews.
1. Getzenberg, R.H., and Coffey, D.S. Tissue Specificity and Cell Death are
Associated with Specific Alterations in Nuclear Matrix Proteins, In: Karr, J.P., Tindall, D.J., Coffey,
D.S., and Smith, R.G. (eds) Molecular and Cellular Biology of Prostate Cancer,
Plenum Press, New York, pg 1-13, 1989.
2. Pienta, K.J., Murphy, B.C., Getzenberg, R.H., and Coffey, D.S. The Tissue Matrix and the Regulation of
Gene Expression in Cancer Cells.
Advances in Molecular and Cellular Biology, 7:131-156, 1993.
3. Getzenberg, R.H. Book Review of Essential Endocrinology. The Physiologist, 409, 1996
4. Getzenberg, R.H. The Tissue Matrix:
Cell Signaling and Hormone Regulation. In: Bittar, E.E. and Bittar, N. (eds)
Principles of Medical Biology, JAI Press, Inc., Greenwich, CT, 10B:643-662, 1997.
5. Konety,
B.R. and Getzenberg, R.H. Novel Therapies for Advanced Prostate
Cancer. Seminars in Urologic
Oncology, 15(1):33-42, 1997.
6. Horton,
M.J. and Getzenberg, R.H. The Role
of the Nuclear Matrix in Tissue Specific Gene Expression. In: Getzenberg, R.H. (ed.) Cell
Structure and Signalling, JAI Press Inc., Greenwich, CT, 185-206, 1997.
7. Getzenberg, R.H. Telomerase, Aging and Cancer. AUA News,
2(4):10, 1997.
8. Getzenberg, R.H. Vitamin D and Normal Prostate Growth
and Differentiation. Nutrition
Report, 15(4):25,32, 1997.
9. Uskokovic,
M.R., Trump, D.L., Getzenberg, R.H.,
and Johnson, C.S. Anticancer
Activity of Vitamin D Analogs. In:
Holick, M.(ed) Vitamin D Physiology, Molecular Biology, and Chemical
Application, Humana Press, Totowa, NJ, in press.
10. Konety,
B.R., Johnson, C.S., Trump, D.L., Getzenberg,
R.H. Vitamin D in the
Prevention and Treatment of Prostate Cancer. Seminars in Urologic Oncology, 17:77-84, 1999.
11. Getzenberg, R.H.,
Reviewer - Unweaving the Rainbow: Science, Delusion, and the Appetite for
Wonder, Author, Richard Dawkins. Oncology Times, 1999.
12. Getzenberg, R.H. The Nuclear Matrix and
Cytoskeleton. The Role of the
Nuclear Matrix and Cytoskeleton in Cancer, In: Chung, L. W. K., Isaacs, W. B.
and Simons, J. W. (eds) Prostate
Cancer: Biology, Genetics, and the New Therapeutics. Humana Press, Totowa, NJ, 2000.
13. Lokeshwar, V.B.
and Getzenberg, R.H. Voided Urine Markers. Lerner, S.P., Schoenberg, M., Sternberg, C.
(Eds): Textbook of Bladder Cancer.
London: T& F-Informa, 2005 (in preparation),
3.
Published
abstracts.
Georgia,
2000.
84. Nguyen,
T-S.T., Konety, B.R., Myers, J.M., and Getzenberg,
R.H. A Novel Highly Specific
and Sensitive Urine-Based Assay for the Detection of Bladder Cancer. American Association for Clinical
Chemistry, La Jolla, CA, 2002.
87. Shah,
U.S. and Getzenberg, R.H. Identification of a Potential Growth
Regulatory Gene Demonstrating a “Field Effect” In Prostate Cancer. American Association for Cancer
Research, San Francisco, CA, 2002
89. Nguyen,
T-S.T., Konety, B.R., Myers, J.M., and Getzenberg,
R.H. A Novel Highly Specific
and Sensitive Urine-Based Assay for the Detection of Bladder Cancer. XVIIth Congress of the European
Association of Urology, Birmingham, England, 2002.
90. Björnsson,
Björn L., Sylvester, R., Getzenberg,
R.H., Oosterlinck, Willem and Goebell, Peter, J. Comprehensive Analysis of Urine-Based Markers for Bladder
Cancer – The Proposed Multicenter Urothelial Neoplasia Detection (MUND)
Study. 2nd
International NCI-EORTC Meeting on Cancer Diagnostics, Washington, D.C., 2002.
91. Getzenberg, R.H.,
Davido, T., Konety B.R., Van Le, T-S.T.
A Highly Specific and Senstitive Urine-Based Assay for the Detection of
Bladder Cancer. Oak Ridge
Conference – Cancer Detection and Monitoring: The Next Generation of Diagnostic
Tools. La Jolla, California, 2002.
92. Kulkarni,
P., Pirozzi, G., Elashoff, M., Waga, I., Munger, W., Dhir, R., Kakehi, Y., and Getzenberg, R.H. Genetic Similarity of BPH from
Individuals with Symptoms and Those with Prostate Cancer. American Urological Association, Annual
Meeting. Orlando, Florida, 2002.
93. Kulkarni,
P., Pirozzi, G., Elashoff, M., Waga, I., Munger, W., Dhir, R., Kakehi, Y., and Getzenberg, R.H. Differentiating Symptomatic and
Asymptomatic BPH: JM-27. American
Urological Association, Annual Meeting.
Orlando, Florida, 2002.
100. Myers, J.M.,
Van Le, T-S.T., and Getzenberg, R.H. Characterization of Nuclear Matrix
Changes Involved in Bladder Cancer
Progression. International Bladder
Symposium, Arlington, VA, 2003.
101 Muscatello,
M., Getzenberg, R.H. Development of an Intelligent Polymerized Crystalline Colloidal Array for
the Detection of Cancer Signature Proteins. 35th Central Regional Meeting of the American
Chemical Society in the Symposium on Analytical Chemistry. Pittsburgh, PA, 2003.
102 Muscatello,
M., Getzenberg, R.H. Development of an In-vivo Sensing Technology for Cancer Signatures. 2004 Pittsburgh Conference. Pittsburgh, PA, 2004.
103. Dhir, R.,
Vietmeier, B., Arlotti, J., Acquafondata, M., Landsittel, D., Masterson, R.,
and Getzenberg, R.H. Identification of Individuals with
Prostate Cancer by Examination of “Negative Biopsies”. American
Urological Association, Annual Meeting.
San Francisco, CA, 2004.
104.
Van Le, T-S.T., Miller, R., Barder, T., Babjuk, M., Potter, D.M., and Getzenberg, R.H. BLCA-4, A Highly Specific Marker
Urine-Based Marker of Bladder Cancer.
American Urological Association, Annual
Meeting. San Francisco, CA, 2004.
105.
Chen, J.J., and Getzenberg, R.H. Using Nuclear Matrix Protein, RCCA-5,
as Biomarker for Renal Cell Carcinoma. Americal Urological Association, Annual
Meeting. San Francisco, CA, 2004.
-------------------------------------------------------------------------------------------------------------------------------
PROFESSIONAL ACTIVITIES
TEACHING:
1994 "The
Role of Nuclear Structure in Gene Regulation and Cancer"
Medical Oncology Grand Rounds, University of Pittsburgh Medical Center
Pittsburgh, PA
1994 "The
Role of the Nuclear Matrix in Prostate Cancer"
Urology Grand Rounds, University of Pittsburgh Medical Center,
Pittsburgh, PA
1994–Present Organized bi-monthly research conference for
investigators, fellows and students with
interests in prostate and GU cancers.
1994–Present Cancer
Research and the Pittsburgh Cancer Institute
Presented a weekly orientation for local High School students sponsored
by the LHAS.
1994- 1995 Sponsored Directed Research (Course #
Bioscience 1903) for undergraduate Jeff Butcher entitled, "Examination of
Vitamin D Receptors on the Nuclear Matrix"
1995 Sponsored
Directed Research (Course # Bioscience 1903) for undergraduate Tisha Nardozza
entitled, "Association of Transcription Factors with the Nuclear
Matrix"
1995 "The
Role of the Nuclear Matrix in Gene Regulation and Cancer"
Department of Pharmacology Seminar, University of Pittsburgh Medical
Center
Pittsburgh, PA
1995 "The
Role of the Nuclear Matrix in Gene Regulation and Cancer"
Human Genetics Seminar - HUGEN 2025,
University of Pittsburgh
Pittsburgh, PA
1995
Pittsburgh Cancer Institute
Orientation
1995 Lectured in Department of Pharmacology Graduate
Course, Cancer Pharmacology
1995 Facilitator
for Medical Student course Cancer
Pharmacology
1995
Comprehensive Examination Committee,
Edwina C. Lerner
Department of Pharmacology
1995- 1996 Training
of Dr. Badrinath R. Konety, Urology Resident
Laboratory Research
1996–Present Thesis
Committee, Yuting Tang
Department of Biology - Donald DeFranco, Thesis Advisor
1996 Pharmacology
Course
Problem Based Learning Session Leader
1996 Lectured in Department of Pharmacology Graduate
Course, Cancer Pharmacology
1996 Lectured
in "From Bench to Bedside”-Frontiers in Cancer Research
University of Chicago
1996 Integrated
Life Sciences - Neoplastic Disease Course (2/96-3/96)
1996 Comprehensive
Examination Committee, Marni Brisson Department of Pharmacology
1996 Training
of Dr. Ajay K. Nangia, Urology Resident
Laboratory Research
1996 "Recent
Advances in Prostate and Bladder Cancer"
Urology Grand Rounds, University of Pittsburgh Medical Center,
Pittsburgh, PA
1996
Laboratory Research Rotation,
Lei Zheng, Department of Pathology, Graduate Student
1996 Training
of Amy Abdulovic, High School Student Intern
1997 Lectured
in Graduate Biochemistry Course, West Virginia University, Department of
Biochemistry, "Nuclear Matrix and Regulation"
1997 Pharmacology
Course
Problem Based Learning Session Leader
1997
UPCI, Biologic Therapy Program,
Biologic Therapy and Transplantation Research
Colloquia, "Novel Approaches to Prostate and Bladder Cancer: Nuclear
Matrix and
Vitamin D"
1997 Cancer
Research, National Defense University, Industrial College of the Armed Forces,
University of Pittsburgh Cancer Institute
1997 Faculty,
1997 American Urological Association Annual Meeting, "Understanding
Molecular Techniques and Their Applications to Urology", New Orleans, LA
1997 Facilitator
for Medical Student Pharmacology
Conference on Host Defenses
1997 Lectured
in Department of Pharmacology Graduate Course, Cancer Pharmacology
1997 Hematology/BMT
Research Seminar. "Novel Approaches to Prostate and Bladder Cancer:
Nuclear Matrix and Vitamin D"
1997 Judge
- 8th Annual Department of Pathology Research Presentations
1997 Cancer
and Cancer Research, Visiting Nurses from Japan, University of Pittsburgh
Cancer Institute
1997 Presented
to UPCI Council Members
1997 "The
Nuclear Matrix and Cancer"
Medical Oncology Grand Rounds, University of Pittsburgh School of
Medicine Pittsburgh, PA
1997 "Cancer
Associated Nuclear Matrix Proteins"
Pathology Research Seminar, University of Pittsburgh School of Medicine,
Pittsburgh, PA
1997-1999 Thesis
Committee, Jimin Liu
Department of Biology - Donald DeFranco, Thesis Advisor
1997 Cancer
and Cancer Research, Nursing Students, University of Pittsburgh Cancer
Institute
1997-1998 Thesis
Committee, Jen-Tzer Gao
Department
of Pathology - Michael J. Becich, Thesis Advisor
1997–1998
Supervised Undergraduate Research Project of Kyle Fisher
1998 Pharmacology
Course
Problem Based Learning Session Leader
1998 Facilitator
for Medical Student Pharmacology Conference on Host Defenses
1998-Present Prostate
Cancer and Cancer Metastasis Lectures of School of Medicine Graduate Course,
"Cancer Biology", University
of Pittsburgh School of Medicine
1998 Lectures
of School of Medicine Course, "Tissue Structure, Growth and
Function".
University of Pittsburgh School of
Medicine
1998 Cancer
Research, National Defense University, Industrial College of the Armed Forces,
University of Pittsburgh Cancer Institute
1998 Faculty,
1998 American Urological Association Annual Meeting, "Understanding
Molecular Techniques and Their Applications to Urology", San Diego, CA
1998-2000 Preceptor for Dr. Badrinath R.
Konety, American Foundation for Urologic Disease and Foundation for Strategic
Bladder Research Scholar
1998-Present Thesis
Committee, Jennifer Guerrero
Department of Biology - Donald DeFranco, Thesis Advisor
1998-2000 Thesis
Committee, Mark Whitmore
Department of Pharmacology - Leaf Huang, Thesis Advisor
1998 Summer
Internship, Amy Abdulovic Grove City College
1998 Comprehensive
Examination Committee, Yadi Tan
Department of Pharmacology
1998 Research
Rotation, M.D., Ph.D. Program Jared Muenzer
1998
Lectured in the Medicine, Ethics
and Society Course, School of Medicine
1998
Presentation on Medical Ethics
to M.D., Ph.D. Students, University of Pittsburgh School of Medicine
1998-Present Co-Director
and Lecturer Neoplasia and Neoplastic Diseases Course, Medical Students, University of
Pittsburgh School of Medicine
1998-1999 Thesis Committee, Michael Gray
Molecular Genetics and Biochemistry –
Bo Liu, Thesis Advisor
1998-Present Faculty
Advisor, Interdisciplinary Graduate Program
Eddy Leman
1999 “New Marker to Detect Bladder Cancer”.
Healthsouth Harmarville Rehabilitation Hospital,
Rehabilitation Mini-Grand Rounds,
Harmarville, PA.
1999 Lectured
on Prostate Biology in “Tissue Structure, Growth and Function”.
University of Pittsburgh School of Medicine.
1999
Pharmacology Course
Problem Based Learning Session Leader
1999
Training of Kate Dougherty – High School Intern
1999 Research
Rotation, Interdisciplinary Graduate Program – Matthew Wilson
1999 Lectured
in the Medicine Ethics and Society Course, School of Medicine
1999 Lectured
in the Foundations of Biomedical Science, School of Medicine
1999 "The
Role of the Nuclear Matrix in Gene Regulation and Cancer"
Pharmacology Research Seminar,
University of Pittsburgh School of Medicine, Pittsburgh, PA
1999 Research
Rotation, Interdisciplinary Graduate Program – Andrew Lepisto
1999
“Cancer and Cancer Research”
Grove City College, Grove City, PA
2000 Lectured
on Prostate Biology in “Tissue Structure, Growth and Function”.
University of Pittsburgh School of
Medicine.
2000 “Current
Advances in Bladder Cancer”
Armstrong County Memorial Hospital – Tumor Board
Kittanning, PA
2000
Summer Internship, Amy Abdulovic Grove City College
2000 Summer
Internship, Roger Bartollota
2000 Course
Director/Integrated Life Sciences Course/Neoplasia and Neoplastic Disease –
University of Pittsburgh
2000
Pathobiology Course – Lecturer
“Nuclear Controls and Transcription Regulation in
Prostate Cancer”
2000-2002 Training
of Tracy Davido, Medical Student IV
Laboratory Research
2000-2002 Training
of Janey Whalen, Ph.D.
Postdoctoral Fellow
2000
Lectured in the Medicine Ethics and Society Course, School of Medicine
2000
Research Rotation, Jared
Muenzer, Medical Student IV
2000-2003
Gisela Brüenagel, M.D.
Postdoctoral Fellow-Feodor Lynen Fellowship Award
2000-2001 Research
Rotation, Interdisciplinary Graduate Program – Lana Hanford
2000 Lectured
in the Foundations of Biomedical Science, School of Medicine
2000
Lectured in the Medicine Ethics and Society Course, School of Medicine
2000
Course Director/Integrated Life
Sciences Course/Neoplasia and Neoplastic Disease
University of Pittsburgh
2001 Lectured
on Prostate Biology in “Tissue
Structure, Growth and Function”
University
of Pittsburgh School of Medicine
2001-Present Interdisciplinary Graduate Program /Thesis
Advisor/Molecular Pharmacology Training Program
Julie Myers
2001 Thesis
Committee,
Department of Pathology – Lei Zheng, Michael J. Becich, Thesis Advisor
1999-2003 Interdisciplinary
Graduate Program/Thesis Advisor – Eddy Leman
2001 Summer
Internship, Pittsburgh Tissue Engineering Initiative, Inc. – Michael Madigan
2001 Summer
Undergraduate Research Program – Elizabeth Pino
2001 Summer
Internship, Amy Abdulovic / Grove City College
2001-2003 Training
of Uzma Shah, Ph.D.
Postdoctoral
Fellow
2001 Cancer
Biology and Therapeutics Course - Lecturer
“Biology of Transformation: Invasion and Metastasis”
Departments
of Pathology & Pharmacology – University of Pittsburgh
2001 Pathobiology
Course – Lecturer
“Nuclear Controls and Transcription
Regulation in Prostate Cancer”
2001 Lectured
in the Foundations of Biomedical Science, School of Medicine
2001 Lectured
in Human Genetics Seminar, School of Medicine
“Novel
Approaches to Urologic Diseases: Cancer and BPH”
2002 Thesis
Committee,
Cellular and Molecular Pathology
Training Program – Lei Zheng,
Michael J. Becich,
Thesis Advisor
2001
Lectured in Integrated Life
Sciences Course/Neoplasia and Neoplastic Disease – University of Pittsburgh
2002-2003 Training
of Meral Guzey, Ph.D.
Postdoctoral
Fellow
2002 - 2003 Summer
Internship – Kristin Stolarczyk / Penn State University
2001-2002
Research Rotation,
Interdisciplinary Graduate Program – Marie Aquilano
2002
Summer Internship – Michael
Madigan
2002
Pittsburgh Development Center Seminar Series – Magee-Womens Research
Institute
“Genomic and Proteomic Approaches to Urologic Cancers
and Benign Diseases – University of Pittsburgh
2002 Lectured
in the Foundations of Biomedical Science, School of Medicine
2002 Thesis
Committee,
Cellular
and Molecular Pathology Training Program - Jeffrey Chou
2002 Thesis
Committee, Robert H. Getzenberg, Thesis Advisor
Cellular and Molecular Pathology Training Program, Eddy
Leman
2002 Summer
Research Undergraduate Program – Henry Richard Johnston, IV
Research
Rotation, Interdisciplinary Graduate Program
2002 Summer
Undergraduate Research Program – Matthew Germinaro
Research
Rotation, Interdisciplinary Graduate Program
2002 Summer
Undergraduate Research Program – Elizabeth Pino
Research
Rotation, Interdisciplinary Graduate Program
2002 Summer
Graduate Research Program/Academic Advisor – Peter McDonald
Research
Rotation, Interdisciplinary Graduate Program
2002
Lectured in Integrated Life
Sciences Course/Neoplasia and Neoplastic Disease – University of Pittsburgh
2002 Cancer
Biology and Therapeutics Course - Lecturer
“Biology of Transformation: Invasion and Metastasis”
Departments
of Pathology & Pharmacology – University of Pittsburgh
2002
Lectured in the Foundations of Biomedical Science, School of Medicine
2002 Pathobiology
Course – Lecturer
“Nuclear Controls and Transcription
Regulation in Prostate Cancer”
2002-2003 Research
Rotation, Interdisciplinary Graduate Program – Sheila Roberts
2003- Present Thesis
Committee
Cellular and Molecular Pathology
Training Program
Katherine
Bright
2003-Present Training
of Manimalha Balasubramani, Ph.D.
Postdoctoral
Fellow
2003- Present Thesis
Committee – Sourabh Kharait
Cellular and Molecular Pathology
Training Program - Alan Wells, Thesis Advisor
2003
Summer Research Undergraduate
Program – Alison Atwood
Research
Rotation, Interdisciplinary Graduate Program
2003 Summer
Research Undergraduate Program – Miranda Sarachine
Research
Rotation, Interdisciplinary Graduate Program
2003 Research
Rotation, Interdisciplinary Graduate Program – Jason D’Antonio
2003-2004 Training
of Joseph Chen, Medical Student
Laboratory Research
2003 Cancer
Biology and Therapeutics Course - Lecturer
“Biology of Transformation: Invasion and Metastasis”
Departments
of Pathology & Pharmacology – University of Pittsburgh
2003 Lectured
in the Foundations of Biomedical Science, School of Medicine
2003 Medical
Student Research Rotation, Mark Perlmutter
2003 - Present Thesis
Committee
Cellular
and Molecular Pathology Training Program – Siva Raja
2003 Comprehensive
Examination Committee/GSR Department of Environmental and Occupational Health
- Cathy Thomas
2002-2003 Preceptor
for Dr. Uzma Shah, American Foundation for Urologic Disease and Research
Scholar
2003 - 2004 Training
of Cynthia Hoffman, PharmD.
Research
Associate
2004 Pharmacology
Seminar
“Genomic
and Proteomic Approaches to Urologic Cancers and Benign Diseases”
Department
of Pharmacology – University of Pittsburgh School of Medicine
2004
Urology Residency Training –
Research Rotation
Benjamin Davies, M.D.
2004 - Present Thesis
Committee - Amanda Boehm
Cellular and Molecular Pathology Training Program -
Janey Whalen, Thesis Advisor
2004 - Present Thesis
Committee – Pamela L. Beatty
Immunology
Training Program - Olja Finn, Thesis Advisor
2004 - Present Thesis
Committee – Jason D’Antonio
Cellular
and Molecular Pathology Training Program – Beth Pflug, Thesis Advisor
2004 Research
Rotation, Grant Cannon
2004 Summer
Research Undergraduate Program – Robin Cline
Research
Rotation, Interdisciplinary Graduate Program
2004 Summer
Research Undergraduate Program – Ellen Leffler
Research
Rotation, Interdisciplinary Graduate Program
2004 Urology
Residency Training – Research Rotation
Glenn Cannon, M.D.
2004 Cancer
Biology and Therapeutics Course - Lecturer
“Biology of Transformation: Invasion and Metastasis”
Departments
of Pathology & Pharmacology – University of Pittsburgh
2004 Thesis
Committee – Greg Gan
Molecular
Pharmacology Program – Ferrucio Galbiati Thesis Advisor
2004 Research
Rotation, Interdisciplinary Biomedical Graduate Program – Martha Milton
RESEARCH:
1. Grant
Support
Active
Grant Number Role
in Project & Years Source
(Funded)___ Grant
Title Percentage
of Effort Inclusive Amount
2 RO1 CA082522-06 Characterization
of the Bladder Principal
Investigator 2000-2005 $1,154,679
(NIH) Cancer
NMP, BLCA-4 11.7%
1 P01 HD39768-01 Collaborative
Urologic Principal
Investigator 2001-2006 $4,981,551
(NIH) Research
In Spinal Cord Injury- 10%
Project 3-Biomarkers of Bladder
Cancer in SCI Individuals
Tessera Inc. Sponsored
Research Agreement Principal Investigator 2002-2004 $647,935
0%
1 R13 CA/DK97015 Prouts
Neck Prostate Cancer Principal
Investigator 2002-2006 $213,389
(NCI) Meeting 0%
NIH-UO1DK063593 MTOPS
Biomarker Unit at Principal
Investigator 2002-2005 $1,270,215
the
University of Pittsburgh 25%
NIH-R01-CA96105-01 Specific
Biomarkers in Bladder Principal
Investigator 2002-2006 $982,642
Cancer
Prevention 10%
5P 30 CA47904-13 Prostate
and Urologic Cancer Program
Co-Director 1999-2004 $3,070,434
(NIH) Program-UPCI
Cancer Center 5%
Core
Grant
Pfizer Inc. Effects
of Doxazosin on
Modulation
of Novel Genes
Assoc.
with Symptomatic BPH Principal
Investigator 2004-2005 $15,000
NIH-R41 CA107448 Novel
Protein Marker for Co-Investigator 2004-2005 $100,000
Prostate
Cancer Detection 5%
1 K12 DK02656-01 Physicians
and Scientist Co-Investigator 1999-2004 $896,805
1 T32 DK07774-01 Training
Program in Urologic 5% $484,795
(NIH) Research
N0I-CN-75018 A
Phase II Clinical Trial of Co-Investigator 1996-2004
$417,835
(NIH) Anti-Androgen
and 5-alpha 0%
Reductase
Inhibitors in Patients
With
Prostate Cancer.
Administration
in the Period
Prior
to Radical Prostatectomy
(Presurgical
Period). Modulation
of
Surrogate Endpoint Biomarkers
(Seb)
DAMD3058093 A
Novel Approach in Prostate Co-Investigator 2001-2004
$541,710
(DOD) In
Prostate Cancer Therapy 8%
N01-CO-17016-32 Development
of an in-vivo Co-Investigator 2001-2004 $1,776,806
(NIH) Sensing
Technology for the 10%
Development
of Biomolecular
Sensors
Previous
Grant Number Role
in Project & Years Source
(Funded) Grant
Title Percentage
of Effort Inclusive Amount
1R55 CA/OD65463 Shannon
Award Principal
Investigator 1995-1997 $50,000
(NIH)
National Kidney Evaluation
of Nuclear Matrix Principal
Investigator 1996-1997 $20,000
Foundation of Protein
Markers in Renal
W. Penn Cell
Carcinoma
Comp. Medical Bladder
Cancer Associated Principal
Investigator 1996-1997 $25,000
Research Fund Nuclear
Matrix Alterations
National Kidney The
Clinical Utility of Renal Principal
Investigator 1996-1997 $30,000
Cancer Assoc. Cell
Carcinoma Associated
Nuclear
Matrix Proteins
Matritech Sponsored
Research Principal
Investigator 1996-1997 $100,000
Agreement
Demeter Demeter
Bio Technologies Ltd. Principal
Investigator 1997-2000
$280,000
NIH-1RO3 HD35878 Spinal
Cord Injury and Principal
Investigator 1998-2000
$150,500
Bladder
Cancer Detection 10%
Lilly and Co. The
Study of LY353381 Principal
Investigator 1998-2000
$8,140
In
Prostate Cancer
NIH-1R29 CA65463 Prostate
Cancer Associated Principal
Investigator 1996-2001
$528,299
Nuclear
Matrix Alterations 25%
TAP Pharm. Sponsored
Research Principal
Investigator 1999-2002 $128,565
Agreement
GeneLogic Sponsored
Research Principal
Investigator 1999-2002 $923,624
Agreement
NIH-1 R13 CA091916 FASEB
Conference: Nuclear Conference
Co-Chair 2001-2001 $36,000
Structure
and Cancer 0%
CaP CURE Induction
of an Immune Co-Investigator 1996-1997 $100,000
Response
to Normal Prostate
Antigens
as an Immunotherapeutic
Strategy
for Prostate Cancer
DOD Role
of Extracellular Matrix Consultant 1997-2000
And
Nuclear Structure
Interactions
in Gene Expression
And
Breast Cancer: Use of a 3D
Culture
Model of Human Mammary
Tumorigenesis
University of Chemoprevention
of Urinary Consultant 2000-
2001 $35,000
Alabama at Bladder
Cancer by NSAIDS
Birmingham
Eichrom Tech., Inc. Sponsored
Research Agreement Principal
Investigator 1999-2003
$254,000
0%
Pending
Grant Number Role
in Project & Years Source
(Funded) Grant
Title Percentage
of Effort Inclusive Amount
NIH-R01CA098707 Characterization
of the Bladder Principal
Investigator 2005-2010 $1,500,000
Cancer
NMP 25%
NIH-R01 DK069401 Characterization
of a Stromal Principal
Investigator 2004-2009 $1,664,009
Specific
Marker of BPH 25%
NIH-R01 CA113609-01 Nuclear
Structure Markers for Principal
Investigator 2005-2009 $1,875,000
Early
Detection of CRC 10%
NIH – U01 CA084968 Serum
Proteomic Biomarkers Prin.
Investigator-Project1 2004-2009 $924,414
For
Colon & Pancreatic Cancer 10%
NIH-U01 Strategic
Partnering to Evaluate Co-Investigator 2005-2010 $2,483,839
Cancer
Signatures 20%
FAMRI A
Marker for Bladder Cancer Principal
Investigator 2004-2006 $100,000
In
Involuntary Smokers
15%
Patent Applications
Partin, A.W., Getzenberg, R.H., and Coffey, D.S.,
“Nuclear Matrix Proteins”, U.S. Serial No.
08/015,624, 1993 (Awarded 9/97).
Getzenberg, R.H., “Nuclear Matrix Proteins,
Polynucelotide Sequences Encoding Them, and Their Use”, U.S. Serial No.
09/418,839, 1999 (Pending).
Getzenberg, R.H. and Bahnson, R.R., “Bladder Cancer
Nuclear Matrix Proteins”, 1995.
U.S.
Patent Number 5,866.535 (Awarded 2/99).
Getzenberg, R.H., “Renal Nuclear Matrix Proteins and
Their Use”, 1997. U.S. Patent Number 6,232,443
(Awarded 5/01).
Munger, W.E., Kulkarni, P., and Getzenberg, R.H.,
GeneLogic – “Identification of cDNAs Associated with Benign
Prostatic Hyperplasia”, 2000 (Pending).
Getzenberg, R.H., Bauer, A.J., Schoen, R.E., Bruenagel,
G., “Colonic Nuclear Proteins, Polynucleotide Sequences, Encoding Them and
Their Use”, 2001 (Pending)
2. Seminars and invited lectureships related
to your research
1990
“Tissue Specificity of the
Nuclear Matrix in Hormone Action”
Annual Meeting of the American Society
for Cell Biology, San Diego, CA.
1991
“Interaction of Tissue Specific
Genes with Tissue Specific Nuclear Matrix Proteins in Rat
Sex Accessory Tissues”
Annual Meeting of the American Society for Cell Biology,
Boston, MA.
1992
“Nuclear Matrix Alterations
Associated with Prostate Cancer in the Dunning Model”
American Urological Association Annual Meeting,
Washington, DC.
1992 “Characterization
of the Tissue Matrix Components of the Normal Prostate and Benign
Prostatic Hyperplasia in the Beagle”
American Urological Association Annual Meeting,
Washington, DC.
1992
“Tissue Specific DNA
Organization and the Nuclear Matrix: Normal and Cancer Cells”
National Institutes of Health, Bethesda, MD.
1993
Gordon Conference on Biological
Structure and Gene Expression
Volterra, Italy
1994
FASEB Conference – Molecular
Genetic Basis of Cell and Tissue Structure and Function
Copper Mountain, CO
1995
“Characterization of Prostate
Cancer Associated Nuclear Matrix Alterations”
American Urological Association Annual Meeting, Las
Vegas, NV
1995 “The
Role of the Nuclear Matrix in Prostate Cancer”
Society for Basic Urologic Research – 5th
Annual Fall Symposium, Chapel Hill, NC
1995 “Recent
Studies in Cancer Associated NMPs: Rat Prostate and Human Bladder”
Matritech, Inc., Cambridge, MA
1996
“Prostate and Bladder Cancer
Associated Nuclear Matrix Proteins”
Hematology/Oncology Research Seminar, University of
Michigan School of Medicine
1996 Prostate
Cancer Prevention Workshop: Investigational Approaches and Opportunities for
Preventing Prostate Cancer, National
Cancer Institute, Annapolis, MD.
1996 “Characterization
of Prostate and Bladder Cancer Associated Nuclear Matrix Proteins” Nuclear
Structure-Gene Expression
Interrelationships, Cambridge Symposia, Bolton Valley, VT
1996
“Prostate and Bladder Cancer
Associated Nuclear Matrix Proteins”
The University of Chicago, Chicago, IL
1996 “Nuclear
Matrix Organization” Faculty, American Urological Association 1996 Research
Conference,
“Advances in Cell Biology”, Houston, TX.
1996 “The
Nuclear Matrix and its Role in Cancer”
Visiting Speakers in Cancer, Case Western Reserve
University, Cleveland, OH
1996 “Novel
Approaches to Prostate Cancer: Nuclear Matrix and Vitamin D”
Prostate Cancer Program, Eli Lilly & Co.,
Indianapolis, IN
1996 “The
Nuclear Matrix and Cancer”
Behring Diagnostics Inc., San Jose, CA
1997
“The Nuclear Matrix and its
Role in Cancer”
Department of Biochemistry, West Virginia University
1997 “Novel
Approaches to Prostate and Bladder Cancer: Nuclear Matrix and Vitamin D”
GU Oncology Conference, University of Michigan, Ann
Arbor, MI
1997 “Nuclear
Protein Matrix”
National Kidney Cancer Association Scientific
Conference, Short Hills, NJ
1997 International
Workshop on Diagnostic and Prognostic Markers in Bladder Cancer,
Barcelona, Spain
1997 Judge-Third
Annual Oakland Scientific Conference, Pittsburgh, PA
1997 “The
Nuclear Matrix and Cancer”
Bard Diagnostic Sciences, Inc., Redmond, WA
1997 Animal
Models of Prostate Cancer – International Commission on Urological Diseases
Purdue University, West Lafayette, IN
1998
“Nuclear Matrix Proteins”
Bladder Cancer: New Concepts in Biology and Therapy,
Sarasota, FL
1998 “Analysis
of Demeter Peptide D2A21”
Pacific West Cancer Foundation, Maui, HI
1998 “Cancer
and Cancer Research”
Seton Hill College, Greensburg, PA
1998 “The
Nuclear Matrix and Cancer”
Ortho-Clinical Diagnostics, Raritan, NJ
1998 “Cancer
Associated Nuclear Matrix Proteins”
Keystone Symposia, The Nuclear Matrix: Involvement in
Genomic Organization,
Function and Cellular Regulation, Copper Mountain, CO
1998 “The
Nuclear Matrix and Cancer”
Bristol-Myers Squibb Oncology, Princeton, NJ
1998 Kidney
Cancer Futures Forum
National Kidney Cancer Association, Chicago, IL
1998 “Approaches
to Prostate and Bladder Cancer: Nuclear Matrix and Vitamin D”
Johnson, Tweardy, Grandis, Steinman Laboratory Group
1998 “Nuclear
matrix Proteins and Cancer Diagnosis”
Ortho-Clinical Diagnostics, Rochester, NY
1998 “Approaches
to Prostate and Bladder Cancer: Nuclear Matrix and Vitamin D”
Life Sciences Division, Lawrence Berkeley National
Laboratory, Berkeley, CA
1998 “Approaches
to Prostate and Bladder Cancer: Nuclear Matrix and Vitamin D”
Department of Urology, Northwestern University School of
Medicine, Chicago, IL
1997
Second International Workshop
on Diagnostic and Prognostic Markers in Bladder Cancer,
Barcelona, Spain
1998
“The Effects of Vitamin D on
Prostatic Growth and Neoplasia” and
“The Nuclear Matrix and Cancer”
Visiting Professorship, Department of
Urology,
University of Iowa, Iowa City, IA
1998 “Utilization
of the Bladder Cancer Specific Nuclear Matrix Protein, BLCA-4, for the
Detection of Bladder Cancer” Society
for Basic Urologic Research Fall Symposium,
Prouts Neck, ME
1998 “Effects
of Vitamin D on Prostate Development and Neoplasia”
New Research Approaches in the Prevention m-d Cure of
Prostate Cancer, American
Association for Cancer Research Special Conference in
Cancer Research, Palm Springs, CA
1999
“Approaches to Prostate and
Bladder Cancer: Nuclear Matrix and Vitamin D” Oncology Center,
Grand Rounds, University of Wisconsin, Madison, WI
1999 Chair,
Think-Tank Workshop on Prostate Cancer
Pittsburgh, PA
1999 “The
Nuclear Matrix and its Role in Cancer”
Joint Graduate Program, University of Minnesota,
Minneapolis, MN
1999 “Cancer
Associated Nuclear Matrix Proteins”
Department of Biology, SUNY at Buffalo, Buffalo, NY
1999 “Nuclear
Matrix Proteins as Markers of Cancer”
Tumor Marker Conference, Santa Barbara, California
1999 “Nuclear
Matrix and Cancer”
Igen International, Inc., Gaithersburg, MD
1999 “Nuclear Matrix and Cancer”
DiaDexus,
San Jose, California
1999
“Prostate Cancer”
UPMC Health News Broadcast –WQED 13
Pittsburgh, PA
1999 “The
Future of Prostate Cancer: Research Horizons”
A
Symposium on Prostate Cancer
NAACP
– Pittsburgh, PA
1999 Panelist,
National Cancer Institute
“Strategies for Developing New Clinical Trials for
Prostate Cancer Chemoprevention”
Baltimore,
MD
1999 “Nuclear Matrix Proteins as
Biomarkers of Prostate Cancer”
NCI Prouts Neck Prostate Cancer
Symposium
Prouts
Neck, ME
1999 “Nuclear
Matrix Proteins as Biomarkers of Cancer”
Bayer Diagnostics, Tarrytown, N.Y.
1999 “Effects of Vitamin D on Prostate Growth,
Differentiation and Neoplasia”
3rd
World Congress on Urological Research
Paris,
France
1999 “Efficacy
of a Synthetic Lytic Peptide in the Treatment of Prostate Cancer”
Joint
Annual Meeting New England and Northeastern Sections of the
American
Urological Association
Bermuda
1999 Visiting Professor – Department of Urology
University
of Medicine & Dentistry of N.J.
New
Brunswick, NJ
2000
“Diagnostics/Markers/Surrogate/Endpoints”
State of the Science Workshop on Superficial Bladder
Cancer
Bethesda, MD
2000
“Nuclear Matrix Proteins as
Biomarkers of Cancer”
Special Lecturer, Department of
Urology
Kyoto University, Graduate School of Medicine
Kyoto, Japan
2000 “Efficacy of a Synthetic Lytic Peptide in
the Treatment of Prostate Cancer”
Annual
Meeting American Urological Association
Atlanta,
Georgia
2000
“Utilization of a Urine Based Assay for BLCA-4 in the Detection of
Bladder Cancer”
Annual Meeting American Urological Association
Atlanta, Georgia
2000 “Novel
Nuclear Matrix Proteins as Urinary Biomarkers”
Interstitial Cystitis Meeting
Minneapolis, MN
2000 Joint
Intergroup Specimen Banking Committee Meeting
Chantilly, VA
2000 Breakout
Session Chair, SOTS Workshop on Superficial Bladder Cancer
Bethesda, MD
2000 “The
Novel Marker BLCA-4 for the Detection of Bladder Cancer”
Nordic Urology Association Meeting
Stockholm,
Sweden
2000 Workshop on the “Mechanisms of Tumor
Metastasis to the Bone: Challenges
and Opportunities”
Bethesda, MD
2001
“Utilization of a Urine Based
Assay for BLCA-4 in the Detection of Bladder Cancer”
2nd Tumor Markers
Conference
Santa Barbara, CA
2001 “Utilization
of a Urine Based Assay for BLCA-4 in the Detection of Bladder Cancer”
3rd
Annual GU Conference
Nemacolin
Woodlands / Farmington, PA
2001
“Novel Findings in Cancer Diagnosis and Treatment”
Pacific West Cancer Foundation/NCC
Miami, FL / Nassau
2001 “Utilization of a Urine Based
Assay for BLCA-4 in the Detection of Bladder Cancer”
European
14th IFCC Congress EUROMEDLAB 2001
Prague,Czech
Republic
2001 “Approaches of
Prostate and Bladder Cancer: Nuclear Structure and Vitamin D”
UroGenesys,
Inc. Santa Monica, CA
2001 “Novel
Technological Applications to Urologic Research”
14th Annual Spring Meeting
– Society for Basic Urological Research
Anaheim,
CA
2001 “Molecular
Differentiation of Histologic and Symptomatic BPH”
Annual
Meeting American Urological Association
Anaheim,
CA
2001 “A
Novel Highly Specific and Sensitive Urine-Based Assay for the Detection of
Bladder Cancer”
Presentation-Eichrom
Anaheim,
CA
2001
“Utilization of a Urine Based
Assay for BLCA-4 in the Detection of Bladder Cancer”
AACC/CSCC 2001-Annual Meeting & Clinical Lab Expo
Chicago, IL
2001 “Nuclear Matrix Proteins as
Cancer Biomarkers”
FASEB
Summer Research Conference
Saxtons
River, Vermont
2001 "Approaches to Prostate and Bladder Cancer: Novel Tumor
Biomarkers and Vitamin D".
Millennium
Pharmaceuticals, Cambridge, Massachusetts
2001 “Men’s Health Issues in Basic
Urologic Research”
Society
for Basic Urologic Research/European Society of Urologic Research Symposium
4th
World Congress in Urologic Research
Tuscon,
Arizona
2001 “New Discoveries
in Prostate Cancer Biology and Treatment”
AACR/Special
Conference in Cancer Research
Naples,
Florida
2001 “A
Novel Highly Specific and Sensitive Urine-Based Assay
for
the Detection of Bladder Cancer”
Second
Annual EDRN Scientific Workshop
Seattle,
Washington
2002 “A Novel Highly Specific and
Sensitive Urine-Based Assay for the Detection of Bladder Cancer”
XVIIth
Congress of the European Association of Urology
Birmingham, England
2002 “Molecular
Imaging in Cancer: Linking”
AACR Special Conference in Cancer Research
Lake
Buena Vista, Florida
2002
“Nuclear Matrix Proteins as
Cancer Biomarkers”
Georgetown University Medical Center/Department of Cell
Biology
Washington, DC
2002
GU SPORE Bladder Cancer
Intergroup Meeting
Houston, TX
2002 NCI-Bladder
and Kidney Progress Review Program (PRG) – Session Leader
2002 “A Highly Specific and Sensitive
Urine-based Assay for the Detection of Bladder Cancer”
AACC/34th Annual Oak Ridge Conference /Cancer
Detection and Monitoring
La Jolla, California
2002 “Bladder Cancer Diagnostics
Expert Consultants Panel”
Geron
Corporation
Menlo
Park, California
2002 “Nuclear Matrix
Proteins – Clinical Use in Bladder Cancer”
ESUR/3rd
International Conference on Prostate Cancer Research
Trento,
Italy
2002 “Prostate Cancer – Early Detection”
RUSSELL/The
Club at Nevillewood
Nevillewood,
PA
2002 “Nuclear Matrix Proteins as Cancer
Biomarkers”
Department of Epidemiology – University of Pittsburgh
Pittsburgh, PA
2002 “Genomic
and Proteomic Approaches To Urologic Cancers and Benign Diseases”
Pittsburgh
Development Center Seminar Series – University of Pittsburgh
Pittsburgh,
PA
2002 Head & Neck Cancer Research Seminar
Eye & Ear Boardroom / University of Pittsburgh
Pittsburgh,
PA
2003 “Moleuclar
Biology and Diagnosis of Bladder Cancer”
3rd
Winter Urological Symposium
Špindlerův
Mlýn
2003 “Nuclear Matrix Proteins as Cancer
Biomarkers”
The University of Texas/MD Anderson Cancer Center
Houston,
Texas
2003 “Utilization of Nuclear
Structure to Develop Tumor Markers”
Nuclear
Structure and Cancer
FASEB
Summer Research Conference
Saxtons
River, Vermont
2003
“Beyond PSA: Molecular
Fingerprints of Prostate Disease”
AUA/Annual
Meeting
Chicago,
IL
2003 “Identification
of Novel Tumor Markers by Proteomic Analysis of Nuclear Structure”
Womens
Cancer Research Seminar Series – Magee Womens Hospital
Pittsburgh,
PA
2003
“Identification of Novel Tumor
Markers by Proteomic Analysis of Nuclear Structure”
PLCO/NLST
Steering Committee Meeting
Santa
Monica, CA
2003 “Nuclear
Matrix Proteins as Bladder Cancer Biomarkers”
International
Bladder Symposium
Arlington,
VA
2003 Takeda Genome Urology 2003
“Proteomics”
Kyoto
Takargaike Prince Hotel
Kyoto,
Japan
2003 “Deciphering the Molecular
Signature of BPH”
AUA/SBUR
Summer Research Conference
Houston,
TX
2003 “Identification of Novel
Tumor Markers by Proteomic Analysis of Nuclear Structure”
TriPath
Oncology, Raleigh Durham, NC
2003 “Identification of Novel
Tumor Markers by Proteomic Analysis of Nuclear Structure”
Department
of Urology Grand Rounds – University of Pittsburgh
2004
“Identification of Novel
Tumor Markers by Proteomic Analysis of Nuclear Structure”
Department
of Urology – Department of Urology Grand Rounds, UT Soutwestern, Dallas, TX
2004 “Proteomic Analysis of
Nuclear Structure – Clinical Use in Bladder and Prostate Cancer”?
Department
of Urology – Department of Urology Grand Rounds, Baylor College of Medicine,
Houston, TX
2004 “Proteomic Analysis of
Nuclear Structure – Clinical Use in Bladder Cancer”
Genitourinary
Malignancies: Translating Laboratory Discoveries into Clinical Realties
GU
Oncology Conference – University of Iowa
Iowa
City, Iowa
2004 “Utilizing Novel Proteomic
and Genomic Approaches to the Diagnosis and Prognosis of Prostate Cancer”
NAACP
Pittsburgh Branch
6th
Annual Father’s Day FIGHT against Prostate Cancer
LeMont,
Pittsburgh, PA
2004 Prostate
and Urologic Cancer Program Seminar
University
of Pittsburgh Cancer Insitute, Pittsburgh, PA
“Utilizing
Novel Proteomic and Genomic to the Diagnosis and Prognosis of Prostatic
Diseases”
2004 “Multimodality
Approach to the Patient with High-Risk Prostate Cancer”
TAP
Pharmaceutical/CME Program
Pittsburgh,
PA
2004 Chair
Late Stage Prostate Cancer a
Multidisciplinary Approach
10th
Prouts Neck Prostate Cancer Meeting
Prouts
Neck, Maine
2005 Nuclear Structure and Cancer
FASEB
Summer Research Conference
Saxtons
River, VT
2005 Chair
Advances
in Biomarkers for Prostate Disease
Paris,
FRANCE
2005 “Discovery of Biomarkers of
Urological Diseases: Proteomics, Genomics and Epigenomic Approaches”
15th
Annual SBUR Meeting
San
Antonio, TX
3. Other research related activities
1992 – 1994 Donald
S. Coffey Lectureship Committee
Society
for Basic Urologic Research
1996 Editor,
“Cell Structure and Signaling”
Advances
in Molecular and Cellular Biology, JAI Press, Greenwich, CT
1997 Ad-hoc
Member, Cell Biology Study Section American Cancer Society
1997 Member,
Study Section – Special Emphasis Panel in Urology, NIDDKD, DRG, National
Institutes of Health
1997 Special
Emphasis Panel Program Project Review Committee,
“Bone Cell Structure and Gene Expression”, NIAMS,
National Institutes of Health
1997 – Present Member,
Education Committee
American
Association for Cancer Research
1998 - Present Cell
Biology Study Section, USAMRMC (DOD) Prostate Cancer Research Program
1998 Member,
Study Section – Special Emphasis Panel – Urology
Research
Centers, NIDDKD, DRG, National Institutes of Health
1998 – 2003 Member,
Society for Basic Urologic Research
Symposium
Organizing Committee
1998 – Present Editorial
Board, Urologic Oncology Survey Section
Urologic
Oncology
1998 Co-Chairperson,
Poster Discussion Session, “Molecular Markers for Cancer
Susceptibility”
American
Association for Cancer Research 1998 Annual Meeting
1998 – 2000 Ad-Hoc
Member, Executive Board
Society
for Basic Urologic Research
1998 – 1999 Member,
Planning Committee
NCI Prouts Neck Prostate Cancer Symposium
1998 – Present Member,
Prostate Research Review Committee Veterans Health Administration
1999 Member,
Research Enhancement Award Program Review Committee
Veterans
Health Administration
1999 – 2003
Treasurer
Society
for Basic Urologic Research
1999 – Present Member,
Peer Review Committee on Cell Structure and Metastasis.
American Cancer Society
1999 - 2000 Ad-Hoc
Member, NIH, National Institutes of Health, Metabolic Pathology Study Section
2000 - Present Ad-Hoc
Member, NCI, National Cancer Institute, PO1 Review Committee
2000 - Present Member,
Editorial Board, The Prostate
2001 – Present
Member, Metabolic Pathology Study Section – Oncological Sciences Integrated
Review Group – Center for Scientific
Review
2001 Co-Director
- FASEB Summer Research Conference
“Nuclear Structure and Cancer”
Saxtons River, Vermont
2001 Section
Chair/NCI, National Cancer Institute, Kidney/Bladder Cancers Progress Review
Group
Chantilly,
Virginia
2001 Co-Director,
AACR Conference: New Discoveries in Prostate Cancer
Naples, FL
2001 - Present Editor – Molecular Oriented Basic Science
Section
Gold
Journal - UROLOGY
2002 - 2007
Director, Prouts Neck Prostate Cancer Meetings
2002 - Present
Chair – Steering Committee of the MTOPS Biomarker Consortium
2003
Co-Chair –
Discussion Session – AUA Annual Meeting
“Beyond
PSA: Molecular Fingerprints of Prostate Disease”
Chicago,
IL.
2003- Present Survey
Editor – Urologic Oncology
2003 P01 Review Panel –
1 P01 CA86871-01A1
Chapel
Hill, NC.
2003 P01
Review Panel – 1 P01 CA093900-01A2
Teleconference
2003 Cancer
Center Review Panel – Site Visit
Irving
Cancer Center, Columbia University
2003 EDRN Review Panel – Site Visit
University
of Texas-M.D. Anderson Cancer Center
1U01CA085078-01
– Bogdan Czerniak, M.D., Ph.D.
2003 P01 Review Panel – 2 P01 CA077739-06A1
Teleconference
2003 Board Member – Gene Therapy and Molecular Biology
2004 P01 Review Panel – 1 P01 CA10406-01A1
Teleconference
2004 P01 Review Panel – 1 P01 CA108964-01
UT
M.D. Anderson Cancer Center, Houston, TX
2004 Member Organizing Committee – International Conference on GU Cancer
Research
University
of Iowa, Iowa City, IA
2004 – 2008 Board Member – American Foundation for Urologic
Diseases (AFUD)
2004 Faculty Member – F1000 Medicine – “Genitourinary System” Section
2004 Member – Publications/Technology Committee
AFUD
2004 Editorial Board – British Journal of Urology International
Section
of Investigative Urology
2004 Society of Basic Urologic Research [SBUR]
Chair-
NIH Operations Committee
2004 – 2008 Member, National Cancer Institute
Subcommittee
C (Basic and Preclinical) NCI
Initial Review Group
2005 Session
Chair - FASEB Summer Research Conference
“Nuclear Structure and Cancer”
Saxtons
River, Vermont
4.
Scientific Reviewer
Cancer Research
Journal of Cellular Biochemistry
Journal of Urology
Urology
Gold Journal – Urology
Urologic Oncology: Seminars and Original Investigations
Experimental Cell Research
Veterans Affairs Research Command
Henry Ford Health Sciences Center
Journal of Clinical Investigation
Cancer Investigation
Journal of the National Cancer Institute
Journal of Cell Science
The Prostate
Urologic Oncology
IUBMB Life
Cancer Chemotherapy and Pharmacology
Cancer Detection and Prevention
Oncology
British Journal of Urology International – BJUI
Asian Journal of Andrology
SERVICE:
1. University
and Medical School
1990
Student Representative – Search
Committee for Selection of the Dean,
Johns
Hopkins University School of Medicine
1990 – 1991 Member,
Rutgers Alumni Association Board of Directors
1994 Presentation
to Wilkinsburg Kiwanis Club on PCI and Prostate Cancer
1995 – Present Editorial
Board, UPCI Clinical News
1995 – 1996 Member,
UPCI Internet Committee
1996 Presentation
to Parkway West Rotary Club on UPCI and Prostate Cancer
1997 – Present Member,
UPCI Annual Scientific Retreat Committee
1997 – Present Chair,
PUCC Search Committee
1997 – Present Chair,
PUCC Pilot Projects Program
1997 – Present Member,
Molecular Oncology, UPCI Search Committee
1997 – Present Member,
Urologic Oncology Search Committee
1998 – 1999 Co-Chair,
Recruitment Committee
The
Integrated Program in Biomedical Sciences
University
of Pittsburgh School of Medicine
1998 Presentation
to USTOO Prostate Cancer Support Group
at Allegheny General Hospital
1998 – 1999 Member
- UPCI Information Systems Steering Committee
1999 Presentation
to Men’s Club, Temple Ohav Shalom on UPCI and Prostate Cancer
1999 Presentation
to USTOO Prostate Cancer Support Group at UPMC
1999 Presentation
to Kidney Cancer Association, Pittsburgh, PA
1999-2000
Chair, Recruitment Committee
The Integrated Program in Biomedical Sciences,
University of Pittsburgh School of Medicine
2000 – Present Member
– Competitive Medical Research Fund (CMRF) Review Committee
2000 – Present Entrepreneurial
Oversight Committee
University of Pittsburgh School of Medicine
2000 – Present Member
– UPMC Shadyside Radiation Safety Committee
2001 Presentation
to UPCI Scientific Advisory Council Meeting
2002 - Present Member
– University of Pittsburgh Technology Transfer Committee
2002 – 2004 Member
– Recruitment Committee
The
Integrated Program in Biomedical Sciences
2003-2004 Chair,
Recruitment Committee
The Integrated Program in Biomedical Sciences,
University of Pittsburgh School of Medicine
2003 Foundations
Course Advisory Committee/University of Pittsburgh
2003 Presentation
to UPCI Scientific Advisory Council Meeting
2003 Member
– Department of Urology Promotions Committee
2004 Member
– Graduate Student Honor Council in the School of Medicine/University of
Pittsburgh
2. Community
activities
1994 - 1997 Vice-President,
Franklin Ridge Community Service Association Board of Directors
1997 – 1998 President,
Franklin Ridge Community Service Association Board of Directors
1998 – 1999 Secretary,
Franklin Ridge Community Service Association Board of Directors
3. Continuing Medical Education (CME)
activities.